Clear Creek Financial Management, LLC
Position in JNJ — Johnson & Johnson
CIK 1784235
SILVERDALE, WA
Position in JNJ
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$2,583,890
+$206,223 QoQ
Shares Held
10,174
+4.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.58%
of 13F equity value
Holder Rank
#2,126
of 4,676 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Clear Creek Financial Management, LLC holds $18,746,377 across 11 Drug Manufacturers - General names. JNJ ranks #2 (13.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
4,281 | $5,134,760 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
10,174 | $2,583,890 | |
| 3 | ABBV |
AbbVie Inc.
|
10,246 | $2,578,303 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
15,209 | $1,921,505 | |
| 5 | MRK |
Merck & Co., Inc.
|
11,408 | $1,465,928 | |
| 6 | NVO |
Novo Nordisk A S
|
28,506 | $1,366,577 | |
| 7 | NVS |
Novartis AG
|
8,250 | $1,292,940 | |
| 8 | AZN |
Astrazeneca PLC
|
6,227 | $1,180,763 |
All Filings in JNJ
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,583,890 | 10,174 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $2,377,667 | 9,727 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $1,983,615 | 9,585 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $1,735,531 | 9,360 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $1,478,772 | 9,681 | Shares | Sole | 2025-07-23 | |
| 2025-03-31 | $1,574,319 | 9,493 | Shares | Sole | 2025-04-28 | |
| 2024-12-31 | $1,105,041 | 7,641 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $989,538 | 6,106 | Shares | Sole | 2024-10-29 | |
| 2024-06-30 | $742,785 | 5,082 | Shares | Sole | 2024-07-25 | |
| 2024-03-31 | $717,233 | 4,534 | Shares | Sole | 2024-04-26 | |
| 2023-12-31 | $657,681 | 4,196 | Shares | Sole | 2024-01-24 | |
| 2023-09-30 | $600,883 | 3,858 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $751,957 | 4,543 | Shares | Sole | 2023-07-17 | |
| 2023-03-31 | $709,590 | 4,578 | Shares | Sole | 2023-04-20 | |
| 2022-12-31 | $778,673 | 4,408 | Shares | Sole | 2023-01-24 | |
| 2022-09-30 | $647,885 | 3,966 | Shares | Sole | 2022-10-24 | |
| 2022-06-30 | $724,240 | 4,080 | Shares | Sole | 2022-07-27 | |
| 2022-03-31 | $736,213 | 4,154 | Shares | Sole | 2022-05-02 | |
| 2021-12-31 | $746,036 | 4,361 | Shares | Sole | 2022-01-21 | |
| 2021-09-30 | $761,795 | 4,717 | Shares | Sole | 2021-10-14 | |
| 2021-06-30 | $786,633 | 4,775 | Shares | Sole | 2021-07-30 | |
| 2021-03-31 | $267,397 | 1,627 | Shares | Sole | 2021-04-23 | |
| 2020-12-31 | $619,447 | 3,936 | Shares | Sole | 2021-02-12 | |
| 2020-06-30 | $578,270 | 4,112 | Shares | Sole | 2020-07-16 | |
| 2020-03-31 | $338,446 | 2,581 | Shares | Sole | 2020-04-23 | |
| No filing history on record for this holder in this stock. | ||||||